How should I manage a patient with a blood glucose of 568 mg/dL after a 12‑unit insulin dose given in the office?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Management of Severe Hyperglycemia (568 mg/dL) After Office Insulin Dose

Send this patient to the emergency department immediately for evaluation of a hyperglycemic crisis and initiation of continuous intravenous insulin infusion. A blood glucose of 568 mg/dL after receiving 12 units of insulin in the office indicates either severe insulin resistance, a hyperglycemic emergency (diabetic ketoacidosis or hyperosmolar hyperglycemic state), or both, and requires hospital-level care.

Why This Patient Needs Hospital Transfer

A glucose level >250 mg/dL raises concern for diabetic ketoacidosis (DKA), and >600 mg/dL suggests possible hyperosmolar hyperglycemic state (HHS) 1. The failure to respond adequately to 12 units of subcutaneous insulin in the office setting indicates:

  • Severity beyond outpatient management capability: This level of hyperglycemia typically requires continuous IV insulin infusion, which is the preferred treatment for hyperglycemic crises 2, 1
  • Need for intensive monitoring: These patients require frequent (every 2-4 hours) monitoring of electrolytes, glucose, renal function, and acid-base status 1
  • Risk of life-threatening complications: Severe hyperosmolarity, electrolyte disturbances (particularly hypokalemia in ~50% of cases), and potential for cardiovascular collapse 1

Critical Actions Before Transfer

While arranging immediate transport:

  1. Check for signs of DKA/HHS:

    • Mental status changes (confusion, lethargy)
    • Signs of severe dehydration (poor skin turgor, dry mucous membranes, hypotension)
    • Kussmaul respirations or fruity breath odor (DKA)
    • Tachycardia
  2. Do NOT give additional subcutaneous insulin - it will be inadequate for this level of hyperglycemia and the patient needs IV insulin therapy 1

  3. Call ahead to the ED to alert them of a potential hyperglycemic crisis requiring ICU-level care

Expected Hospital Management

The receiving facility will implement a hyperglycemic crisis protocol 1:

  • IV insulin infusion: Starting with 0.1 units/kg/hour (typically 5-7 units/hour in adults) after excluding severe hypokalemia (K+ <3.3 mEq/L) 1
  • Aggressive fluid resuscitation: Initial 1-1.5 L of 0.9% saline in the first hour, then continued rehydration based on hemodynamic status 1
  • Electrolyte replacement: Particularly potassium (20-40 mEq/L in IV fluids once K+ >3.3 mEq/L) to prevent life-threatening hypokalemia 1
  • Target glucose reduction: 50-75 mg/dL per hour until glucose reaches 250 mg/dL (DKA) or 300 mg/dL (HHS), then maintain with dextrose-containing fluids and reduced insulin infusion 1

Common Pitfall to Avoid

Do not attempt to manage this level of hyperglycemia with additional subcutaneous insulin doses in the office. Subcutaneous insulin is only appropriate for mild DKA and cannot provide the rapid, titratable control needed for severe hyperglycemia 1. The patient requires continuous IV insulin infusion with intensive monitoring that only a hospital setting can provide 2, 3.

The goal is glucose reduction of 50-75 mg/dL per hour—too rapid correction risks cerebral edema, while inadequate treatment allows progression of metabolic decompensation 1.

References

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Research

Insulin Therapy in Hospitalized Patients.

American journal of therapeutics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.